In 2005, two chemists decided to work together to develop libraries of cyclic peptides—strings of amino acids formed in the shape of a circle—that could be used to treat a range of infectious diseases, autoimmunity and cancer. Thanks to their flexibility, these cyclic peptides can access different parts of a protein target and so bind to …
Read online article by Ron Leuty, Reporter at San Francisco Business Times
Startup Circle Pharma Inc., a UCSF and UC Santa Cruz spinout devising ways to disrupt a wide variety of diseases from inside cells, will work with Pfizer Inc. on two drug programs.
The financial value of the collaboration, as well as the amount of see […]